Johnson & Johnson(JNJ) - Stock detail

Johnson & Johnson

US
JNJ
Johnson & Johnson(Listing date: 09/25/1944)

Johnson & Johnson was incorporated in New Jersey in 1887. Johnson & Johnson and its subsidiaries are engaged in the research and development, manufacturing and sale of various products in the healthcare field. Johnson & Johnson is a holding company, with its operating companies located in nearly all countries around the world. The company's primary focus is on products related to human health and well-being. The company is divided into two business segments: Innovative Medicine and MedTech.

AI Rating

Rating methodology
Latest close (chg%)223.24+0.16%
Buy price
215.00
Target price228.00
Sell price218.50
P/E TTM25.50
P/E20.43
Confidence80%
Risk score70/100
AI Summary
Dominant technical downtrend with price below all key moving averages, severe institutional selling (MFI 0.37), and massive overhead supply from 76% of holders underwater creates unfavorable risk-reward. Fundamentals provide long-term floor but not near-term catalyst. Capital preservation dictates reducing exposure.

Alpha Score

0-10
  • Trend（Score 0/10）

    No summary available

  • Valuation（Score 6/10）

    The current price of $223.24 appears slightly undervalued relative to normalized target ranges. Valuation multiples are premium but justified for this type of company, with forward PE of 20.43 and TTM PE of 25.50. High P/S and P/B ratios are structural and not immediate red flags.

  • Financial strength（Score 6/10）
    JNJ's financial health shows a mixed but generally stable picture with sufficient liquidity, moderate leverage, and overall stability. The company is capable of meeting its obligations, though leverage warrants monitoring.
  • Profitability（Score 8/10）
    JNJ demonstrates strong and improving profitability metrics with high margins, though recent quarterly data shows volatility due to non-recurring items. Return metrics are solid, indicating efficient use of capital.
  • Sentiment（Score 0/10）
    No summary available
Latest price
$223.24+0.16%
Market cap537.39B
P/E TTM25.50
P/E20.43
Volume6.5M
Turnover1.45B